To investigate clinical, virological and immunological parameters and better understand the etiopathogenesis of AIDS-related leukoencephalopathies and demyelinating diseases a longitudinal survey was performed. Clinical observations and MRI examinations were performed on 160 eligible HIV+ HAART treated patients: 33 MRI+ and 45 MRI-patients were enrolled in the study, together with two groups of control constituted by 20 Multiple Sclerosis (MS) patients and 27 healthy subjects (HC). JCV and Human Herpesviruses DNA was searched in CSF every six months. Immunological evaluation consisted of measurement of PBMC production of TNF\uf061, IFN\uf067, IL-2, and apoptotic cells, previous and after JCV VP1 HLA-restricted peptides and MBP stimulat...
Progressive multifocal leukoencephalopathy (PML) is a subacute demyelinating disease of the brain ca...
BACKGROUND: Leukoencephalopathies in HAART-treated, HIV-positive patients include progressive multi...
BACKGROUND: Leukoencephalopathies in HAART-treated, HIV-positive patients include progressive multif...
INTRODUCTION: To investigate clinical, virological and immunological parameters and better understan...
Background: HAART has changed the AIDS scenario, but neurological disorders including PML and JC vir...
OBJECTIVE: HAART has changed the scenario of HIV-related neurological disorders but the incidence of...
We are performing a longitudinal survey to investigate AIDS related leukoencephalopathies, including...
INTRODUCTION: After the introduction of HAART, the reduction of HIV related CNS disorders has been l...
BACKGROUND: HAART has changed the scenario of HIV-related neurological disorders but the incidence o...
INTRODUCTION: The use of HAART in the treatment of HIV infection has led to a marked reduction in AI...
Progressive multifocal leukoencephalopathy (PML) usually is a rapid and fatal demyelinating disease ...
John Cunningham virus (JCV), the etiological agent of progressive multifocal leukoencephalopathy (PM...
Objectives. To analyze virological and immunological features of AIDS-related progressive multifocal...
Background: The introduction of highly active antiretroviral therapy (HAART) has significantly modif...
Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the CNS of immu...
Progressive multifocal leukoencephalopathy (PML) is a subacute demyelinating disease of the brain ca...
BACKGROUND: Leukoencephalopathies in HAART-treated, HIV-positive patients include progressive multi...
BACKGROUND: Leukoencephalopathies in HAART-treated, HIV-positive patients include progressive multif...
INTRODUCTION: To investigate clinical, virological and immunological parameters and better understan...
Background: HAART has changed the AIDS scenario, but neurological disorders including PML and JC vir...
OBJECTIVE: HAART has changed the scenario of HIV-related neurological disorders but the incidence of...
We are performing a longitudinal survey to investigate AIDS related leukoencephalopathies, including...
INTRODUCTION: After the introduction of HAART, the reduction of HIV related CNS disorders has been l...
BACKGROUND: HAART has changed the scenario of HIV-related neurological disorders but the incidence o...
INTRODUCTION: The use of HAART in the treatment of HIV infection has led to a marked reduction in AI...
Progressive multifocal leukoencephalopathy (PML) usually is a rapid and fatal demyelinating disease ...
John Cunningham virus (JCV), the etiological agent of progressive multifocal leukoencephalopathy (PM...
Objectives. To analyze virological and immunological features of AIDS-related progressive multifocal...
Background: The introduction of highly active antiretroviral therapy (HAART) has significantly modif...
Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the CNS of immu...
Progressive multifocal leukoencephalopathy (PML) is a subacute demyelinating disease of the brain ca...
BACKGROUND: Leukoencephalopathies in HAART-treated, HIV-positive patients include progressive multi...
BACKGROUND: Leukoencephalopathies in HAART-treated, HIV-positive patients include progressive multif...